John Michael Longo
CIK: 0002106601
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BLTE
BELITE BIO, INC
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Longo John Michael
Longo John Michael (SEC CIK 0002106601) files insider reports with the SEC as Director of BELITE BIO, INC (BLTE).
Signal8 holds 1 ownership filing by Longo John Michael, a Form 3, filed on Mar 18, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Longo John Michael's filings is in MONROE TOWNSHIP, NJ.
Other insiders filing for BELITE BIO, INC (BLTE)
- Chuang Hao-Yuan, Chief Financial Officer
- Lin Yu-Hsin, Chief Executive Officer
- Chen Wan-Shan, Director
- Scholl Hendrik Peter, Chief Medical Officer
- MATA NATHAN L., Chief Scientific Officer
- Chen Xiao-Hui, Director